AlloVir and Kalaris Therapeutics Announce Agreement for Transformational Merger to Create Company Focused on Diseases of the Retina | Morningstar

AlloVir and Kalaris Therapeutics Announce Agreement for Transformational Merger to Create Company Focused on Diseases of the Retina Kalaris is a clinical-stage biopharmaceutical company founded by Samsara BioCapital and focused on developme
Read more...